{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:23:51Z","timestamp":1773368631774,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007675","name":"International Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["P24R32003"],"award-info":[{"award-number":["P24R32003"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108784","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:20:22Z","timestamp":1763184022000},"page":"108784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Deep learning and molecular dynamics reveal promising EZH2 inhibitors for epigenetic cancer targeting"],"prefix":"10.1016","volume":"120","author":[{"given":"Damilola A.","family":"Omoboyowa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6567-248X","authenticated-orcid":false,"given":"Temitope C.","family":"Aribigbola","sequence":"additional","affiliation":[]},{"given":"Babasola","family":"Aiyeku","sequence":"additional","affiliation":[]},{"given":"Damilola S.","family":"Bodun","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5709-0244","authenticated-orcid":false,"given":"Oluwatoba E.","family":"Oyeneyin","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108784_bib1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/js9901007","article-title":"The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship","volume":"88","author":"Abraham","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-0716-3441-7_7","article-title":"Applications of molecular dynamics simulations in drug discovery","volume":"2714","author":"Al-Rawashdeh","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108784_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084147","article-title":"Structural context of disease-associated mutations and putative mechanism of auto-inhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain","volume":"8","author":"Antonysamy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib5","first-page":"12772","article-title":"Discovery of potential HER2 inhibitors from Mangifera indica for the treatment of HER2-Positive breast cancer: an integrated computational approach","volume":"39","author":"Balogun","year":"2021","journal-title":"J. Biomol. Stru. Dyn."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108784_bib6","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phy."},{"issue":"15","key":"10.1016\/j.compbiolchem.2025.108784_bib7","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108784_bib8","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1021\/acs.jcim.0c00915","article-title":"REINVENT 2.0: an AI tool for de novo drug design","volume":"60","author":"Blaschke","year":"2020","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110672","article-title":"De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning","volume":"195","author":"Bodun","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Sci"},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108784_bib11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib12","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0387","article-title":"Opportunities and obstacles for deep learning in biology and medicine","volume":"15","author":"Ching","year":"2018","journal-title":"JR Soc. Interface"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108784_bib13","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An Nlog(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phy."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib14","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"5-6","key":"10.1016\/j.compbiolchem.2025.108784_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108784_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular Dynamics Simulation for All","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108784_bib17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: Equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys. Rev. A Gen Phys."},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108784_bib18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/bioinformatics\/bts139","article-title":"MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations","volume":"28","author":"Hospital","year":"2012","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108784_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol."},{"issue":"21","key":"10.1016\/j.compbiolchem.2025.108784_bib20","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/molecules24213839","article-title":"Heterocycles in medicinal chemistry","volume":"24","author":"Jampilek","year":"2019","journal-title":"Mol"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of Simple Potential Functions for Simulating Liquid Water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phy."},{"issue":"17","key":"10.1016\/j.compbiolchem.2025.108784_bib22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2217\/fon-2020-1244","article-title":"EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed\/refractory follicular lymphoma","volume":"17","author":"Julia","year":"2021","journal-title":"Future Oncol."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108784_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.compbiolchem.2025.108784_bib24","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.compbiolchem.2025.108784_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib26","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12859-019-3135-4","article-title":"Comprehensive ensemble in QSAR prediction for drug discovery","volume":"20","author":"Kwon","year":"2019","journal-title":"BMC Bioinform"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108784_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5483\/BMBRep.2022.55.12.174","article-title":"The role of EZH1 and EZH2 in development and cancer","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108784_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/14756366.2021.1999237","article-title":"Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors","volume":"37","author":"Lin","year":"2022","journal-title":"J. Enz. Inhib. Med. Chem."},{"issue":"1-3","key":"10.1016\/j.compbiolchem.2025.108784_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108784_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-024-00812-5","article-title":"Reinvent 4: Modern AI-driven generative molecule design","volume":"16","author":"Loeffler","year":"2024","journal-title":"J. Chemin.."},{"issue":"21","key":"10.1016\/j.compbiolchem.2025.108784_bib32","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: Increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108784_bib33","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"13","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nat"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nat"},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108784_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10822-021-00378-6","article-title":"Identification of novel EED-EZH2 PPI inhibitors using an in silico fragment mapping method","volume":"35","author":"Misawa","year":"2021","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108784_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","volume":"443","author":"Morris","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib39","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals: looking beyond intuition","volume":"317","author":"M\u00fcller","year":"2007","journal-title":"Sci"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib40","series-title":"Molecular Electrostatic Potentials: Concepts and Applications","first-page":"105","author":"Murray","year":"1996"},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108784_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2022.100147","article-title":"Exploring molecular docking with E-pharmacophore and QSAR models to predict potent inhibitors of 14-\u03b1-demethylase protease from Moringa spp","volume":"4","author":"Omoboyowa","year":"2022","journal-title":"Pharm. Res Mod. Chin. Med"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40203-024-00284-3","article-title":"Deciphering phosphodiesterase-5 inhibitors from\u00a0Aframemum melegueta: computational models against erectile dysfunction","volume":"12","author":"Omoboyowa","year":"2024","journal-title":"In Silico Pharmacol."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib44","first-page":"101450","article-title":"Investigation of\u00a0Cnidium monnieri\u00a0compounds as phosphodiesterase-5 antagonists in erectile dysfunction via molecular docking and dynamic simulation.","volume":"45","author":"Omoboyowa","year":"2024","journal-title":"Infor. in Med. Unlocked"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib45","first-page":"1","article-title":"Exploration of Bauhinia variegata compounds as STK-16 antagonists via molecular docking and dynamic simulation for oncogenic pathway targeting","volume":"68","author":"Omoboyowa","year":"2025","journal-title":"Nucleus"},{"key":"10.1016\/j.compbiolchem.2025.108784_bib46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/ed045p581","article-title":"Hard and Soft Acids and Bases-HSAB, Part I: Fundamental Principles","volume":"45","author":"Pearson","year":"1968","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00214-002-0363-9","article-title":"The fundamental nature and role of the electrostatic potential in atoms and molecules","volume":"108","author":"Politzer","year":"2002","journal-title":"Theor. Chem. Acc."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108784_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib49","unstructured":"Schr\u00f6dinger Release 2024. Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2024; Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY, 2024."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108784_bib50","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/j100373a017","article-title":"Use of the electrostatic potential at the molecular surface to interpret and predict nucleophilic processes","volume":"94","author":"Sjoberg","year":"1990","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nat"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108784_bib53","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108784_bib54","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"15","key":"10.1016\/j.compbiolchem.2025.108784_bib55","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.bmcl.2016.05.018","article-title":"Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays","volume":"26","author":"Wu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108784_bib56","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1021\/acs.jcim.5c00135","article-title":"Multi-target natural compounds for ischemic stroke treatment: integration of deep learning prediction and experimental validation","volume":"65","author":"Zhou","year":"2025","journal-title":"J. Chem. Info Model."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108784_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2018.06.001","article-title":"EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation","volume":"34","author":"Zingg","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125004463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125004463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:44:08Z","timestamp":1773326648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125004463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S1476927125004463"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108784","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning and molecular dynamics reveal promising EZH2 inhibitors for epigenetic cancer targeting","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108784"}}